In a preprint from Grosch and co-authors, the recently described AAVMYO capsid was applied to treat P635L and R636Q Rbm20 mutation-induced DCM in mice, using a split-intein derived ABE (Grosch et al., 2022 preprint). Here, RBM20 is linked to familial dilated cardiomyopathy.